CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to GILD

Optimized Background Regimen (OBR)

Phase 3
Gilead Sciences, Inc. (GILD)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Mar '27
GILDPhase 2

Oral Lenacapavir Phase 2 Est. Readout

Optimized Background Regimen (OBR)
Mar 2027~STALE
CT.gov
00%
Competitive Landscape

1 competitor in HIV-1-infection

View Full Landscape
Drug Information

Target Indication

HIV-1-infection

Clinical Trial

NCT06749054

Last updated: 1/7/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.